EAM
EXAS

EdenTree Asset Management’s Exact Sciences EXAS Stock Holding History

EdenTree Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-43,325
Closed -$2.95M – 64
2024
Q3 		$2.95M Hold
43,325
– – 0.85% 33
2024
Q2 		$1.83M Hold
43,325
– – 0.58% 34
2024
Q1 		$2.99M Hold
43,325
– – 0.95% 27
2023
Q4 		$3.21M Hold
43,325
– – 0.99% 29
2023
Q3 		$2.95M Buy
43,325
+250
+0.6% +$21.2K 1.16% 26
2023
Q2 		$4.04M Buy
+43,075
New +$3.36M 1.39% 26

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EdenTree Asset Management's EXAS Position: Q4 2024 in Review

EdenTree Asset Management sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 43,325 shares — an estimated $2.95M sold.

EdenTree Asset Management first reported a position in EXAS in Q2 2023 and held it in 6 quarters. The position peaked at $4.04M in Q2 2023. 593 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • EdenTree Asset Management reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • EdenTree Asset Management sold 43,325 Exact Sciences shares in Q4 2024, an estimated $2.95M.
  • EdenTree Asset Management first reported a position in Exact Sciences in Q2 2023 and held it in 6 quarters.
  • EdenTree Asset Management's Exact Sciences position peaked at $4.04M in Q2 2023.
  • 593 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on EdenTree Asset Management's 13F filing for Q4 2024, filed 18 Feb 2025.